Cost-Effectiveness Analysis of a Maternal Vaccination Program Against Respiratory Syncytial Virus in Norway.
Saved in:
| Title: | Cost-Effectiveness Analysis of a Maternal Vaccination Program Against Respiratory Syncytial Virus in Norway. |
|---|---|
| Authors: | Værnø SG; Oslo Economics, Oslo, Norway., Oteiza F; Oslo Economics, Oslo, Norway., Gillebo M; Oslo Economics, Oslo, Norway., Havdal LB; Department of Pediatric and Adolescent Medicine, Akershus University Hospital, Nordbyhagen, Norway., Mwaura DN; Pfizer AS, Oslo, Norway., Husby Ø; Pfizer AS, Oslo, Norway., Solli O; Pfizer AS, Oslo, Norway., Lie K; Pfizer AS, Oslo, Norway., Bugge C; Oslo Economics, Oslo, Norway. |
| Source: | Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2025; Vol. 19 (9), pp. e70161. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic) Linking ISSN: 17502640 NLM ISO Abbreviation: Influenza Other Respir Viruses Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
